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Helicobacter cinaedi was ﬁrst isolated from rectal cultures from homosexual men in 1984. In the 1980s to
mid 1990s, the microorganism was mainly isolated from samples from homosexual men or immuno-
compromised patients; however, during the last two decades, H. cinaedi has been isolated from
immunocompromised and from immunocompetent individuals worldwide. In Japan, the isolation of this
microorganism was ﬁrst reported in 2003. Since then, many cases have been reported in hospitals across
the country. Despite many reports, the etiological properties and pathogenicity of H. cinaedi remain
elusive; however, we are increasingly able to recognize some of the features and the clinical relevance of
infection. In particular, a long incubation period is essential for detection in an automatic blood culture
system and many of the recent isolates are resistant to both macrolides and quinolones. Furthermore,
there is an association between infection and severe or chronic illnesses, such as meningitis or arte-
riosclerosis, in addition to mild diseases such as fever, abdominal pain, gastroenteritis, proctitis, diarrhea,
erysipelas, cellulitis, arthritis, and bacteremia.
In this review, we introduce the current knowledge and our latest ﬁndings relating to H. cinaedi.
© 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
The genus Helicobacter is a gram-negative spiral bacterium,
belonging to the family Helicobacteriaceae of the order Campylo-
bacterales within the class Epsilonproteobacteria.
Almost all members of genusHelicobacter show curved spiral (S-
shape) or fusiform rods that are 0.2e1.2  1.5e10 mm. Spiral cells
may be tightly or loosely wound depending on the species and on
the culture age and condition. Cells in old cultures or those exposed
to air become coccoid. Periplasmic ﬁbers may be observed on the
cell surface in certain species (Fig. 1).
Helicobacter cinaedi was ﬁrst reported as a Campylobacter-like
organism type-1 (CLO-1) in 1984 by Fennell et al. [1] They
described three different types of CLOsdCLO-1, CLO-2 (later named
“Campylobacter fennelliae”), and CLO-3 (still unnamed)dbased ony, School of Pharmacy, Aichi
i Prefecture 464-8650, Japan.
mura).
d The Japanese Association for Infectibiochemical traits (nitrate reduction and odor-producing ability)
andmembrane spot DNAeDNA hybridization results. The following
year, Totten et al. [2] proposed the name “Campylobacter cinaedi”
for CLO-1 organisms, although they demonstrated that there are
two genetic groups within CLO-1 type, namely, CLO-1a and CLO-1b,
with DNAeDNA hybridization values of 42e51%. Comparable
values between CLO-2 and CLO-3 strains were far lower (less than
7%). These data and the lack of biochemical differences between
CLO-1a and CLO-1b groups allowed the authors to include both
within a single species. Thus, “C. cinaedi” is genetically diverse,
involving at least two genomospecies. In 1991, “C. cinaedi” and also
“C. fennelliae” were moved into the genus Helicobacter [3] as
H. cinaedi and Helicobacter fennelliae [4].
To date, the validation of 33 species in genus Helicobacter has
been proposed, but only seven species have been isolated from
human clinical specimens (Table 1, Fig. 2). Helicobacter pylori,
classiﬁed as a “gastric-Helicobacter species” [5], is the most well
known species of the genus Helicobacter, although H. cinaedi, Hel-
icobacter bilis, Helicobacter canadensis, Helicobacter canis,
H. fennelliae, and Helicobacter pullorum, classed as “enterohepaticous Diseases. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.
Fig. 1. SEM image of Helicobacter species. a) H. cinaedi (PAGU611; a whole genome determined strain) showing S-shaped and bipolar ﬂagella. b) H. bilis (PAGU599T) showing a
fusiform cell body encircled by tightly wound periplasmic ﬁbers and multiple sheathed ﬂagella (15,000, Bar ¼ 1.0 mm).
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clinical specimens.
There is an invalid species name related to the genus Heli-
cobacter known as “Flexispira rappini” (sometime referred as “Hel-
icobacter rappini”). “F. rappini” was ﬁrst proposed by Bryner et al.
[6,7] for a strain group of ultrastructurally distinct, urease-
producing strains isolated from lambs, dogs, canine, ovine, and
humans. Since this ﬁrst study, strains have been identiﬁed as
“F. rappini” by 16S rRNA gene sequence comparison, despite notable
morphological and phenotypic differences [8e10]. In 2000, Dew-
hirst et al. [11] reported that “F. rappini” strains represent at least 10
Helicobacter taxa, and then H€anninen et al. [12,13] fell into each
taxon as a valid Helicobacter species (Table 2). Only taxon 7 (one
strain isolated from dog stomach) and taxon 10 (three strains iso-
lated from cotton-top tamarin) have not been clear their taxonomic
positions. Indeed, the title of the 16S rRNA gene sequence infor-
mation under the DDBJ/NCBI/EBI accession number M88138
(ATCC43879) is still ‘Helicobacter sp. “Flexispira taxon 8” 16S ribo-
somal RNA gene’. This information may be a cause of misunder-
standing and the researcher should carefully read both the title andTable 1
All validity proposed members of the genus Helicobacter.
Species Host animal Valid year
Enterohepatic Helicobactera
1 H. cinaedib Human, Hamster 1991
2 H. canisb Dog, Human 1994
3 H. bilisb Mouse, Dog, Human 1997
4 H. canadensisb Human 2002
5 H. fennelliaeb Human 1991
6 H. pullorumb Chicken, Human 1995
7 H. cholecystus Hamster 1997
8 H. ganmani Mouse 2001
9 H. hepaticus Mouse 1994
10 H. mesocricetorum Hamster 2000
11 H. muridarum Mouse, Rat 1992
12 H. pametensis Bird, Swine 1994
13 H. rodentium Mouse 1997
14 H. trogontumc Rat 1996
15 H. typhlonius Mouse 2002
16 H. anseris Goose 2006
17 H. brantae Goose 2006
18 H. marmotae Woodchuck, cat 2006
19 H. mastomyrinus Rodent 2006
20 H. equorum Horse 2007
a “Enterohepaic-Gastric" categories were basically according with Solnick et al. [5].
b Only seven species has been isolated from human specimen. Some reports described
there is no report, to our knowledge, has isolated the organism.
c Two isolation cases of H. trogontum from human clinical specimen have been reporte
been yet).
Besides these species, “Candidatus Helicobacter bovis" (gastric helicobacter) has been prthe annotated text. Other provisional names, “Helicobacter west-
meadii” [14] and “Helicobacter sp. strainMainz,” have been assigned
to H. cinaedi [15].
H. cinaedi was ﬁrst isolated from rectal swabs obtained from
homosexual men with proctitis, proctocolitis, and enteritis [1], but
the number of reports of H. cinaedi infection has been steadily
growing throughout the last two decades. Because early reports
mainly described the isolation of these microorganisms from ho-
mosexual men or immunocompromised patients, and their pres-
ence was attributed to human immunodeﬁciency virus infection,
agammaglobulinemia, or some other underlying disease [16e21],
the organisms were thought to be related to speciﬁc hosts.
Recently, however, given that increasing numbers of infections
have also been reported in immunocompetent patients [22e25],
the patient group affected by H. cinaedi is larger than originally
thought.
In Japan, the ﬁrst report describing the isolation of H. cinaedi
was published in 2003 [26]. Since then, isolation of this microor-
ganism has been reported in patients regardless of gender and
within a wide age range, from newborns to the elderly, by manySpecies Host animal Valid year
Gastric Helicobacter
21 H. pylorib Human, Monkey 1989
22 H. acinonychis Cheetah 1993
23 H. aurati Hamster 2002
24 H. baculiformis Cat 2008
25 H. bizzozeronii Dog 1996
26 H. cetorum Dolphin, Whales 2006
27 H. cynogastricus Dog 2006
28 H. felis Cat, Dog 1991
29 H. heilmannii Monkey 2012
30 H. mustelae Ferret 1989
31 H. nemestrinae Monkey 1991
32 H. salomonis Dog 1997
33 H. suis Pig 2008
the detection of H. suis, H. felis, H. hepaticus, or H. ganmani using genetic methods but
d on the Japanese Society for Clinical Microbiology Meeting (Journal report has not
oposed in 1999 [95].
Fig. 2. Phylogenetic relationships among all members of the genus Helicobacter, based on 16S rRNA gene sequence. Distances were calculated by the neighbor-joining method.
The numbers at the branching points are bootstrap values. C. fetus subsp. fetus was used as the out group. The numbers in parenthesis are the accession numbers of the gene
sequences. The “gastric-Helicobacter species” (indicated by shaded text) formed one well-separated cluster, excluding H. mustelae and H. aurati.
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that the H. cinaedi positive rate in blood cultures was 0.06% (6/
16,743 samples) of total blood samples and 0.22% (6/2718 samples)
of blood samples with any positive culture, based on a prospective
multicenter analysis in 13 hospitals over 6 months in Tokyo. This
microorganism is not a clinically scarcity. Indeed, we have
encountered many cases of H. cinaedi cellulitis and bacteremia that
occurred continuously in both immunocompromised and immu-
nocompetent subjects in hospitals. Now, we recognize that this
microorganism should be considered a causative agent of nosoco-
mial infection [24,28,29]. The association of this microorganism
with a variety of human infections is receiving a growing amount of
attention.
2. Diseases caused by H. cinaedi
H. cinaedi infection causes many kinds of symptoms including
fever, abdominal pain, gastroenteritis, proctitis, diarrhea, erysip-
elas, cellulitis, arthritis, neonatal meningitis, and bacteremia [30].
Recently, a case of meningitis in a healthy adult and that of an
axillobifemoral bypass graft infection in an immunocompetent
patient were also reported [31,32].
Numerous reports have described bacteremia caused by
H. cinaedi rather than by other Helicobacter species. This may be
because this organism has a strong ability for vascular invasion
resulting in bacterial translocation from the intestinal tract to the
vascular system. Among the many cases of H. cinaedi bacteremia,
the main symptom is fever. However, various symptoms are
important to note. Fever is typically accompanied by arthritis and
cellulitis at various sites in the body, which can be regarded either
as the primary site of infection of bacteremia or a secondary focus
of infection through the bacteremia.In our experience, some patients had a sudden onset of local ﬂat
cellulitis (salmon-pink in color) accompanied by fever and an in-
crease in C-reactive protein levels at various times after orthopedic
surgery (range, 8e113 days; mean, 29 days) (Fig. 3) [24]. Cellulitis
was often multifocal with no wound infection. Many of these pa-
tients had been treated for fracture and were immunocompetent.
Regarding a new disease relating to H. cinaedi infection, we
recently found that H. cinaedi infection is involved in the progres-
sion of atherosclerosis. To investigate the relationship of H. cinaedi
infection and atherosclerosis, we ﬁrst analyzed H. cinaedi infection
in the human atherosclerotic aorta by using immunohistochem-
istry with a speciﬁc anti-H. cinaedi antibody. Surprisingly, H. cinaedi
antigenwas clearly detected in atherosclerotic plaques in almost all
postmortem human specimens [33], where it was colocalized with
macrophages. These observations strongly suggest that H. cinaedi
may be closely associated with atherosclerosis in humans. We
further investigated the effect of H. cinaedi infection on the devel-
opment of atherosclerosis and its molecular mechanisms by using
Apoeshl atherosclerosis model mice. Apoeshl mice orally infected
with H. cinaedi for 8 weeks developed atherosclerosis in the aorta
more extensively than uninfected control mice, as conﬁrmed by
lipid staining with Oil Red O for atherosclerosis plaques (Fig. 4(A))
[34]. To the best of our knowledge, this is ﬁrst evidence of the
involvement of H. cinaedi infection in the development of
atherosclerosis.
The chronic inﬂammatory response is a widely accepted key
mechanism in the progression of atherosclerosis [35,36]. Gene
expression analysis by real-time reverse transcription-PCR revealed
signiﬁcantly increased expression of inﬂammation-related genes,
such as inducible nitric oxide synthase, interleukin-1, and Toll-like
receptor 4, in aortic tissues of H. cinaedi-infected Apoeshl mice
compared with those in uninfected control mice [34]. Mediators
Table 2
Taxonomical ascription of “Flexispira rappini".
Taxon Valid name Representative strain
1 H. trogontum ATCC 43968
2 H. bilis ATCC 49314
3 H. bilis ATCC 49320
4 H. trogontum ATCC 49310
5 H. trogontum ATCC 43966
6 H. trogontum 8581T (¼type strain of H. trogontum)
7 Not determined 1302/Dog-4
8 H. bilis ATCC 43879
9 H. bilis ATCC 51630
10 Not determined 97-6149-5
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wall, such as CeC motif chemokine 2 and intercellular adhesion
molecule-1, were also upregulated in infected mice. Moreover,
nested PCR analysis, which is a highly speciﬁc and sensitive
detection method for H. cinaedi that we recently developed [37],
clearly showed that H. cinaedi DNA and RNA existed in the aorta of
infected mice [34]. These ﬁndings suggested that oral infection by
H. cinaedi might translocate to vascular tissue and induce chronic
inﬂammation in the aorta, subsequently leading to atherosclerotic
plaque formation.
We further investigated the mechanism of atherosclerosis pro-
motion by H. cinaedi infection by using in vitro experiments. The
accumulation of lipids inmacrophages, which is known as foam cell
formation, is thought to be a critical step in the development of
atherosclerosis. Thus, we examined the effect of H. cinaedi infection
on foam cell formation in cultured macrophages derived from
mouse and human [34]. Twenty-four hours after H. cinaedi was
added to the culture medium, macrophages had markedly accu-
mulated lipid droplets, which is the hallmark of foam cell formation
(Fig. 4(B)). Uninfected cells and H. pylori-infected cells did not show
such accumulation of lipid droplets, suggesting that H. cinaediFig. 3. (A) A typical skin lesion of cellulitis caused by H. cinaedi. Cellulitis is typically
salmon-pink in color and is accompanied by swelling (arrows). (B) Clinical course of a
patient with cellulitis caused by H. cinaedi. At a same time as a sudden onset of
cellulitis, body temperature (BT), white blood cell count (WBC), and C-reactive protein
(CRP) levels were elevated. After taking Sulbactam/Ampicillin (SBT/ABPC), these
symptoms quickly improved.speciﬁcally induced foam cell formation. Further examination of
the mechanism of foam cell formation induced by H. cinaedi
infection revealed that a change in the metabolism of cholesterol
induced by infection may be involved. Speciﬁcally, H. cinaedi
infection of macrophages increased the expression of LDL receptor,
known to be involved in cholesterol intake, in macrophages. Also,
H. cinaedi infection of macrophages decreased the expression of the
ATP-binding cassette transporter G1 (ABCG1), which is thought to
be involved in the excretion of cholesterol to outside of the mac-
rophages. Although the detailed molecular mechanisms of the
changes in expression of the LDL receptor and ABCG1 during
H. cinaedi infection remain unclear, these changes would affect
intracellular cholesterol metabolism and cause an accumulation of
cholesterol. These results suggest that H. cinaedi infection promotes
the development of atherosclerosis through chronic vascular
inﬂammation, macrophage activation, and subsequent foam cell
formation (Fig. 5).
Some reports have suggested that infection by speciﬁc microbes
may be involved in the pathogenesis of atherosclerosis. These mi-
crobes include various pathogens, such as Chlamydia pneumoniae
and Porphyromonas gingivalis [38,39]. However, the exact mecha-
nisms involved in the promotion of atherosclerosis and to what
extent they are related to human atherosclerosis is not fully un-
derstood. Our recent ﬁndings presented above showed a new
mechanism of atherosclerosis development promoted by bacterial
infection. These may be related to the vascular tropism of H. cinaedi
and frequent recurrences. Further investigation is needed to clarify
the involvement of H. cinaedi infection in human atherosclerosis
and the detailed molecular mechanisms involved in H. cinaedi
promotion of foam cell formation in macrophages. Additional in-
vestigations to determine the etiological role of H. cinaedi in the
development of atherosclerotic cardiovascular diseases are also
warranted.3. Virulence factors
Only two virulence factors have been reported in the literature:
cytolethal distending toxin (Cdt) and alkyl hydroperoxide reduc-
tase (AhpC). Cdt is a lethal toxin to eukaryotic cells as a result of
apoptosis induction and cell cycle arrest in host eukaryotic cells
[40,41]. AhpC is an enzyme that converts various alkyl hydroper-
oxides to their corresponding alcohols, and can change hydrogen
peroxide to water. This enzyme contributes to microorganism
survival in host conditions via the protection of the cells from
oxidative stress [42].
During our investigation to determine the complete genome
sequence of a human clinical isolate (PAGU 611) from the blood
sample of a cellulitis subject, we revealed that the microorganism
holds a Type VI secretion system (T6SS) which is thought to be
related to its virulence [43]. T6SS is a kind of complex multi-
component secretion machine, often called a “needle” or “molec-
ular syringe”. In many cases, T6SS delivers bacteriolytic effectors to
target cells, such as other bacteria or eukaryotic hosts, and in some
cases is involved in symbiotic interactions with eukaryotic hosts
[44,45].
In the case of Helicobacter hepaticus, another enterohepatic
species that is harbored in mouse intestines, T6SS was reported to
play an important role in persistent colonization to promote a
balanced relationship with the host via the T6SS directed anti-
inﬂammatory gene expression proﬁles in intestinal epithelial cells
and CD4þ T cells [46]. Another report described an association
between VgrG1, a secreted protein of T6SS, and bacterial colitogenic
potential [47]. The role of the T6SS in H. cinaedi infection is not
clear; however, there might be a similar virulence function.
Fig. 4. (A) Promotion of atherosclerosis by H. cinaedi infection in Apoeshl mice aortas. Mice were killed at 8 weeks after oral infection and atherosclerotic lesions in the aortic
sinus were stained with Oil Red O (red). Scale bars, 200 mm. Modiﬁed from Ref. [34]. (B) Foam cell formation induced by H. cinaedi infection in cultured mouse peritoneal
macrophages. Cells were infected with H. cinaedi (MOI of 0.1 for 24 h) and stained with Oil Red O. Nuclei were stained with DAPI. Scale bars, 20 mm. Modiﬁed from Ref. [34].
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tors, described above, cdt and ahpC genes, and also several putative
virulence-related proteins, such as ﬁbronectin- and ﬁbrinogen-
binding proteins, neutrophil activation protein, and Campylobacter
jejuni invasion antigen B [43]. The type strain of H. cinaedi, another
complete genome determined strain [48], has all of the above-
mentioned (putative) virulence factors; thus, these factors might
be commonly harbored within the human isolates.
Further investigation is needed to clarify the virulence of this
microorganism.
4. Clinical laboratory tests
It is well known that H. cinaedi is a fastidious and slow-growing
organism and that detection and cultivation are extremely difﬁcult.
In this section, methods of detection, culture, and identiﬁcation are
described, as well as the description of new taxon for the genus
Helicobacter.
4.1. Detection on blood culture system
Isolates of H. cinaedi are mainly obtained from blood and, to a
lesser extent, fecal samples. In fact, H. cinaedi is in many cases ﬁrst
detected from blood culture using an automatic blood culture
system. Nowadays, many hospital laboratories employ an auto-
matic blood culture system, such as the BACTEC or BacT/ALERTsystems. Recently, another blood culture system, VersaTREK, has
been introduced in Japan.
Because H. cinaedi are slow-growing organisms, a relatively
prolonged incubation time is generally required. In many reports,
and in our experience, 4e10 days are needed for a positive result in
the culture bottle of an automatic blood culture system, such as the
BACTEC system using an aerobic bottle. Therefore, once the culture
test is ﬁnished within 3e4 days, the possibility of detection can
become critically low due to not reaching the detection limit.
Detection reports of H. cinaedi using the BacT/ALERT system are
very limited. In the case of the BacT/ALERT system, H. cinaedi has
been detected using both aerobic and anaerobic bottles [22,49,50].
In our experience, the VersaTREK system is superior for the
detection of this microorganism. Because the VersaTREK system
provides excellent growth ability and is highly sensitive, H. cinaedi
isolates can be detected very quickly. Some clinical laboratory
technologists have reported being able to detect H. cinaediwithin 3
days [51]. In our preliminary experiment using ﬁve H. cinaedi iso-
lates, the VersaTREK system detected all isolates within 3 days,
whereas other systems needed more incubation time or detection
failed [52].
4.2. Culture
H. cinaedi isolates essentially required microaerobic conditions
(5e10% O2) and high humidity. Blood agar plates stored in a
Fig. 5. Schematic representation of a possible mechanism of atherosclerosis promotion by H. cinaedi. Based on the data in Ref. [34].
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H. cinaedi because thewater contentmay be reduced; therefore, the
use of fresh medium is strongly recommended. It is well known
that the growth of H. cinaedi is accelerated by adding hydrogen gas
(5e10%) to the microaerobic conditions. It is preferable to use such
gas conditions (e.g. 6% O2, 7% H2, 7% CO2, and 80% N2) in the initial
culture step of the clinical specimen or in the culture bottle to in-
crease the culture success rate. Unfortunately, many commercially
available microaerobic gas generating packs, such as the Gas-Pak
system, can deoxidize and generate CO2 but not supply hydrogen
gas; therefore, H. cinaedi growth sometimes fails or is insufﬁcient.
H. cinaedi cultured on an agar plate may appear as a swarming thin
ﬁlm, which is difﬁcult to identify visually. Therefore, the culture
should be carefully checked on the plate.
Many selective media are suitable for the isolation of H. cinaedi.
Baba et al. [53] reported that many different selective media for
Campylobacter or Helicobacter, such as Skirrow and Butzler Blaser,
can be used, with the exception of CCDA (charcoal-cefazolin-so-
dium deoxycholate agar), which failed to grow the H. cinaedi iso-
lates [54,55].
Tomida et al. [56] reported that “Helicobacter medium” (Nissui
Pharm. Co. Ltd) is excellent, because it has good potential for sup-
porting the growth of H. cinaedi isolates. Furthermore, because the
medium contains a serum (not erythrocytes) and reduction-
reactive dyes, the growing bacteria are easy to observe, even in
ﬁlm form, due to their purple color against the translucentmedium.
These selective media would be useful for isolating H. cinaedi
from specimens such as feces or environmental samples. Another
approach using ﬁltration method is described in “Cape Town
Campylobacter and Helicobacter Protocol”, a document issued by
the South Central Association for Clinical Microbiology, a not-for-
proﬁt organization (http://www.scacm.org/index.htm).4.3. Identiﬁcation
The biochemical identiﬁcation of this organism is problematic
due to unstable phenotypic reactions. For example, results of the
42 C (Celsius temperature) growth test led to disagreement be-
tween researchers; Lawson [30] described a negative result but
Kiehlbauch et al. [57] reported a positive result. The results of the
alkaline-phosphatase test are difﬁcult to read because the gradualcolor changes are dependent on the incubation time and certain
strains give only the faintest hint of color [58].
Due to these unstable phenotypic reactions and a lack of sub-
stantial data sets, commercially available identiﬁcation kits do not
produce reliable results. Therefore, identiﬁcation has been based on
nucleotide sequence or species-speciﬁc polymerase chain reaction
(PCR). We have developed a nested PCR system with high speci-
ﬁcity and sensitivity (c.a. 102 CFU/ml) for detecting H. cinaedi based
on the sequence of the known virulence factor gene, cdtB [37]. By
using this cdtB gene-based PCR detection system, we identiﬁed
more than 200 isolates received from various hospitals across the
country. Another advantage of using PCR techniques is that culture
is unnecessary. Since the culture of H. cinaedi isolates is very difﬁ-
cult and sometimes, as mentioned above, cells fail to even grow, the
present DNA detection test is convenient, as it can be directly
performed even in these cases from the contents of a culture bottle
using PCR.
Analysis of 16S rRNA gene sequences is one of the most common
approaches for investigating the phylogenetic positions of bacterial
strains; however, Vandamme et al. [59] reported a problem due to
misidentiﬁcation of H. cinaedi using 16S rRNA gene sequences. The
isolate believed to be H. cinaediwas located some distance from the
phylogenetic cluster of the type strain, it is required careful
consideration. Yet almost all isolates that we found were located
within or very close to the type strain's cluster, and were correctly
identiﬁed using 16S rRNA gene phylogenetic analysis. As described
above, the species H. cinaedi includes at least two genetically
diverse microorganisms, and Vandamme et al. [59] used certain
strains such as the previously named “Helicobacter sp. strain
Mainz”, or certain canine isolates; therefore, the antecedents of the
strains should be clariﬁed.
Kuhnert and Burnens [60] highlight another potential source of
error in the identiﬁcation of H. cinaedi. ATCC 35863 was designated
and distributed as a type strain of H. cinaedi but is actually H. fen-
nelliae. Identiﬁcation operations involve matching data sets ob-
tained from unknown isolates with those of previously described
taxa, so any mislabeling of the latter can result in unknown isolates
being misidentiﬁed [60]. Fortunately, this problem has already
been ﬁxed (ATCC 35863 is now labeled as H. fennelliae).
PCR-DGGE (denature gradient gel electrophoresis) method us-
ing ampliﬁed 16S rRNA gene for the identiﬁcation of Helicobacter
species has also been reported [61]. Other gene sequences, such as
Table 3
Pattern of primary antibiotics of H. cinaedi isolates.
Range of MIC (mg/ml) MIC50 (mg/ml) MIC90 (mg/ml) n
Penicillins
Ampicilllin 0.5e32 8 16 79
Amoxicillin
1e16 8 8 45
(0.5e32) (4) (8) (46)
Carbenicilin 0.5e16 8 16 38
Cephalosporins
Cefepime 0.5e32 4 8 45
Ceftriaxone 2e8 4 8 8
Carbapenemsa
Imipenem
0.06e4 0.12 0.5 29
(0.031e0.25) (0.063) (0.125) (46)
Aminoglycosides
Gentamicin
0.12e2 0.5 1 79
(0.25e1) (0.5) (0.5) (46)
Tetracycline
Tetracycline 0.06e4 0.25 1 79
Minocyclineb (0.016e0.25) (0.063) (0.125) (46)
Macrolides
Erythromycin 16e>64 >64 >64 8
Clarithromycin (2e>128) (64) (>128) (46)
Quinolones
Ciproﬂoxacin
0.06e64 16 64 79
(16e128) (64) (128) (46)
Levoﬂoxacin 0.06e>64 4 64 75
Moxiﬂoxacin 0.06e32 0.5 8 75
Metronidazole
Metronidazole 0.06e>64 2 64 11
The data were basically collected by the broth microdilition method [72].
MIC values reported by Rimbra et al. [75] using agar dilution method are described
in the parentheses.
a Meropenem also showed low MIC values (&0.12 mg/ml) in our small scale ex-
amination (n ¼ 4).
b MIC value of minocycline in our small scale examination also showed&0.12 mg/
ml (n ¼ 4).
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[62], DNA gyrase protein B-subunit (gyrB) gene [63], 60 kDa heat
shock protein gene (hsp60) [64], 23S rRNA gene [65], and urease
protein B-subunit (ureB) gene [13] have also been used in phylo-
genetic studies of the genus Helicobacter. These analysis methods
are certainly thought to be useful, but each method has particular
strengths and limitations relating to the accumulation of sequence
data and the distinguishing powers. Therefore, researchers must
carefully consider the advantages and disadvantages of each anal-
ysis method.
4.4. Description of a new taxon within the genus helicobacter
“Recommended minimal standards for describing new species
of the genus Helicobacter” was published in 2000 by the Interna-
tional Committee of Systematic Bacteriology subcommittee on the
taxonomy of Campylobacter and related bacteria [66,67]. The
recommendation stated that at least ﬁve strains should be used and
both phenotypic and molecular data collected. Some basic
biochemical testing procedures and the medium formulas for Hel-
icobacter and Campylobacter are described by On and Holmes
[58,68,69]. The molecular data described in the recommendation
includes DNA G þ Cmol%, almost full-length 16S rRNA gene se-
quences (more than 1450 bp) including intervening sequences (if
any), DNAeDNA hybridization data, and others. To propose a new
species or subspecies, researchers should include these data.
5. Antimicrobial susceptibility testing
There are no recommended guidelines for susceptibility testing
and the treatment of diagnosed infections with H. cinaedi.
In 1991, one report clearly stated that H. cinaedi failed to grow
during testing for antimicrobial susceptibility by a broth micro-
dilution method [70]. Antimicrobial susceptibility testing for
H. cinaedi isolates has been carried out using the agar dilution
method [18,50,57], which is too cumbersome to carry out routinely
in hospital laboratories. The E-test is an alternative method used to
measure antimicrobial susceptibility [25,71]; however, because
H. cinaedi has a migratory growth pattern, the E-test may be inac-
curate due to unclear edges around the growth inhibition zone.
Comparative analysis of the growth ability of H. cinaedi isolates
in some broth media revealed that modiﬁed Levinthal broth is
suitable for supporting the growth of H. cinaedi strains in 96-well
format microplates [72]. Minimum inhibitory concentration (MIC)
values obtained from the broth microdilution method using the
modiﬁed Levinthal broth are almost same as those obtained from
the traditional agar dilution method. From these data, Tomida et al.
[72] concluded that a broth microdilution method for antimicrobial
susceptibility testing of H. cinaedi, which can be performed easily, is
a reliable method for determining the MIC.
H. cinaedi strains generally show low MIC values for carbape-
nems, aminoglycosides, and tetracycline (MIC90 &1 mg/ml for
imipenem, gentamicin, and tetracycline). Penicillins and cephalo-
sporins show moderate MIC values (MIC90 ¼ 16 mg/ml for ampi-
cillin, and carbenicillin, MIC90 ¼ 8 mg/ml for amoxicillin, cefepime,
and ceftriaxone). In contrast, H. cinaedi, which has well known
resistance to macrolides [57,73], has particularly high MIC values
(MIC90 > 64 mg/ml for erythromycin). Although there are some
reports from before the current decade describing susceptibility to
quinolones [18,21,22,57,74], more recently in Japan and elsewhere
H. cinaedi isolates have shown high resistance to quinolones
(MIC90 ¼ 64 mg/ml for ciproﬂoxacin and levoﬂoxacin) due to point
mutation(s) of DNA gyrase genes. Almost the same MIC values are
reported by other researchers [75]. MIC values of recent isolates
from several hospitals in Japan are summarized in Table 3.It is well known that efﬂux pumps contribute to antimicrobial
resistance in many cases. The resistance nodulation cell division
(RND) type multidrug efﬂux transporters are the clinically relevant
chromosomally encoded fundamental antimicrobial resistance
mechanisms in Gram-negative bacteria [76]. We identiﬁed two
genes (locus-tags HCN_0595 and HCN_1563) in the chromosome of
H. cinaedi PAGU 611 encoding the hydrophobe/amphiphile efﬂux-1
sub-family of the RND family [43,77]. The genes were also
conserved in other H. cinaedi genomic strains of CCUG 18818 and
ATCC BAA-847 [48]. HCN_0595 orthologs are found in various spe-
cies among the genus Helicobacter (e.g. H. pylori 26695 and
H. hepaticus ATCC 51449), while HCN_1563 orthologs are found only
in enterohepatic Helicobacter species (e.g. H. hepaticus ATCC 51449)
examined. A phylogenetic tree was constructed using COBALT soft-
ware (Fig. 6) [78]. HCN_1563 pump is between CmeB of C. jejuni and
BepE pump of Brucella suis, both of which are major antimicrobial
resistance contributors, while HCN_0595 pump is between HefC of
H. pylori and CmeF of C. jejuni, both of which are likely to be small or
secondary contributors. The CmeABC pump contributes to the ac-
quired resistance of C. jejuni to macrolides and ﬂuoroquinolones
[79,80]; HCN_1563 pump of H. cinaedi may be associated with
resistance to these drugs. Another eight putative drug transporter
genes (one belonging to the major facilitator family, one to the ATP-
binding cassette family, two to the multidrug and toxin extrusion
family, and four to the small multidrug resistance family) are found
in the genome ofH. cinaedi PAGU 611. The orthologs are also encoded
inH. cinaediATCC BAA-847 andH. hepaticusATCC 51449 [77]. It is not
clear how the gene products operate and how they contribute to
antimicrobial resistance, and further investigation is needed.
Fig. 6. Two RNDmultidrug efﬂux pumps in H. cinaedi PAGU 611 are similar to those
of CmeB of C. jejuni and HefC of H. pylori, respectively. The tree constructed using
the COBALT program [78] is shown. The accession number of each pump is in the text.
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Various antibiotic agents alone or in combination have been
successfully used for treating infections caused by H. cinaedi
[18,21,24,29,74]. Symptoms caused by this microorganism, such as
fever or cellulitis, resolve after 2 or 3 days of drug therapy. In some
cases the symptoms disappear spontaneously and the patients
becomes asymptomatic, although the microorganisms are still
present in the patients and will recur [81]. The prognosis is
generally good, but it should be recognized that about 30e60% of
patients have recurrent symptoms [24,26,74,82,83]. The CDC rec-
ommends long-term therapy of about 2e6 weeks, rather than
short-term therapy of up to 10 days [74]. Many other reports also
describe long-term chemotherapy for the prevention of recurrent
symptoms [22,74,81].
No recommended guidelines are available for the treatment of a
diagnosed infection of H. cinaedi. As an alternative guide to
chemotherapy, it may be noted that in testing for H. cinaedi in
recurrent-bacteremia cases, the approach used is an interpretation
of the susceptibility to clarithromycin based on the CLSI (Clinical
and Laboratory Standards Institute; http://clsi.org/) guidelines for
H. pylori and on published reports for metronidazole and amoxi-
cillin [84,85]. For other antibiotics, interpretation is based on CLSI
guidelines for gram-negative bacilli [81]. Although such a chal-
lenging report exists, authorized guidelines for the treatment of
H. cinaedi infections, including the clinical breakpoints of antimi-
crobial agents, have not been established.
7. Epidemiological analysis
The infection route of H. cinaedi has not been clariﬁed. However,
H. cinaedi has been found in awide range of animals, from domestic
pets to wild animals, including cats, dogs, hamsters, rats, foxes, and
rhesus monkeys [5,86e88].
Many reports have raised a suspicion of zoonotic transmission
from animals to humans [89,90]. Orlicek et al. [47] reported that
H. cinaedi was responsible for bacteremia and meningitis in a
newborn whose mother cared for a pet hamster during her preg-
nancy. Lasry et al. [22] reported H. cinaedi-related septic arthritis
and bacteremia in an immunocompetent patient who worked oc-
casionally as a shepherd and had contact with cows and farm an-
imals. Indeed, H. cinaedi is reported to be a member of the normal
intestinal ﬂora in hamsters [91]. Another report [92] describes
certain enterohepatic Helicobacter species, including H. cinaedi, are
located mainly in sites in the lower intestinal tract such as the
cecum and colon in dogs, rather than in the upper parts such as the
as duodenum, jejunum, or ileum. It is likely that contact infection
has occurred from animal to human. However, there are no reportsof the simultaneous isolation of H. cinaedi in human patients and
close contact animals. It is noteworthy that H. cinaedi isolates from
human, dog, and hamster formed distinct ribotype pattern groups
according to their host source [57]. This kind of discrepancy be-
tween human and animal isolates has been recently recognized by
using the matrix-assisted laser desorption/ionization time of ﬂight
mass spectrometry system [93].
Epidemiological analysis methods such as plasmid proﬁles,
pulse-ﬁeld gel electrophoresis, randomly ampliﬁed polymorphic
DNA, and multilocus sequence typing have been proposed for
H. cinaedi isolates [24,28,57].
We have developed a nested PCR system, as mentioned above
[37], to directly catch the bacterial DNA (antigen detecting system)
in the clinical specimens, and have established an immunological
diagnosis method (antibody detecting test) with high speciﬁcity to
detect the exposure history of H. cinaedi [94]. Using these methods,
we have analyzed many healthy subjects working in a hospital
(doctors, nurses, staff members, etc.) and found some healthy in-
dividuals infected with H. cinaedi [37]. This ﬁnding suggests
asymptomatic carriers exist, and may be related to nosocomial
infections.
Further investigations are needed to clarify the complete
infection route and the nosocomial transmission route of H. cinaedi
infection.
8. Conclusion
It appears that, because H. cinaedi is thought not to cause acute
severe disease, little importance has been placed on this organism.
However, we now know that it likely causes nosocomial infections,
is difﬁcult to eradicate, and has a high incidence of recurrence.
Furthermore, an association with chronic illnesses such as
arrhythmia and arteriosclerosis has been pointed out in recent
years.
Therefore, there is a need to rapidly establish guidelines for the
use of antimicrobial agents, susceptibility testing, and the treat-
ment regimen in diagnosed H. cinaedi infection cases. In addition, it
is important to elucidate the infection route. To our knowledge, no
medical center or clinic that has detected recurrent H. cinaedi
infection has successfully eradicated it. Taking into account the
variety of environmental or animal vector routes, both the route
and the mechanism of infection by this microorganism should be
clariﬁed. Furthermore, we need to carefully monitor and under-
stand the trends in H. cinaedi infections.
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